Brugada syndrome diagnostic criteria

Brugada syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Brugada syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Examples of Type I Brugada Syndrome
Chest X Ray
Echocardiography or Ultrasound
Electrophysiologic Studies
Genetic Testing
Treatment
Treatment
Drugs to Avoid
Drugs to Preferably Avoid
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Brugada syndrome diagnostic criteria On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Brugada syndrome diagnostic criteria All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Brugada syndrome diagnostic criteria
CDC on Brugada syndrome diagnostic criteria
Brugada syndrome diagnostic criteria in the news
Blogs on Brugada syndrome diagnostic criteria
Directions to Hospitals Treating Brugada syndrome
Risk calculators and risk factors for Brugada syndrome diagnostic criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The diagnosis of brugada syndrome is based upon electrocardiographic and clinical criteria.

Diagnostic criteria

1. The presence of Type 1 ST-segment elevation in more than one right precordial lead (_V1-V₃). Type I ST elevation can be observed either spontaneously or following the administration of a sodium channel blocking agent.
2. One or more of the following criteria must also be met:

• Family history of sudden cardiac death (SCD) (<45 years old)
• Documented ventricular fibrillation (VF)
• Polymorphic ventricular tachycardia
• Coved-type ECG changes in family members
• Inducibility of ventricular tachycardia (VT) with programmed electrical stimulation (PES)

3. The patient is also diagnosed as having Brugada syndrome when a Type 2 (saddleback pattern) or Type 3 ST-segment elevation is observed in more than one right precordial lead under baseline conditions and that can be converted to the diagnostic Type 1 pattern following administration of a sodium channel blocker.